Extension of US Patent and Trademark Office’s Cancer Immunotherapy Pilot Program – The National Law Review
|
Extension of US Patent and Trademark Office's Cancer Immunotherapy Pilot Program
The National Law Review On June 19, 2017, the U.S. Patent and Trademark Office (USPTO) announced that it would be extending the Cancer Immunotherapy Pilot Program, which permits patent applications pertaining to cancer immunotherapy to be examined in an expedited fashion … |
